Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)

PHASE3CompletedINTERVENTIONAL
Enrollment

446

Participants

Timeline

Start Date

March 16, 2018

Primary Completion Date

November 14, 2018

Study Completion Date

November 14, 2018

Conditions
Seasonal Allergic Rhinitis (SAR)
Interventions
DRUG

GSP 301 NS

1 spray in each nostril twice daily for 14 days

DRUG

GSP 301 Placebo NS

1 spray in each nostril twice daily for 14 days

Trial Locations (32)

19406

Glenmark Investigational Site 18, Mission Viejo

27607

Glenmark Investigational Site 8, Raleigh

29303

Glenmark Investigational Site 6, Spartanburg

30060

Glenmark Investigational Site 13, Marietta

31312

Glenmark Investigational Site 26, Savannah

40215

Glenmark Investigational Site 28, Louisville

45231

Glenmark Investigational Site 11, Cincinnati

45242

Glenmark Investigational Site 29, Cincinnati

48197

Glenmark Investigational Site 25, Ypsilanti

53288

Glenmark Investigational Site 23, Greenfield

64093

Glenmark Investigational Site 27, Warrensburg

65203

Glenmark Investigational Site 12, Columbia

65401

Glenmark Investigational Site 10, Rolla

68114

Glenmark Investigational Site 15, Omaha

73034

Glenmark Investigational Site 2, Edmond

74136

Glenmark Investigational Site 33, Tulsa

76712

Glenmark Investigational Site 20, Waco

Glenmark Investigational Site 31, Waco

78130

Glenmark Investigational Site 1, New Braunfels

78229

Glenmark Investigational Site 9, San Antonio

78759

Glenmark Investigational Site 5, Austin

80907

Glenmark Investigational Site 21, Colorado Springs

84020

Glenmark Investigational Site 22, Draper

90723

Glenmark Investigational Site 30, Paramount

92108

Glenmark Investigational Site 17, San Diego

910762

Glenmark Investigational Site 32, Ontario

21236-5992

Glenmark Investigational Site 14, Baltimore

20814-2672

Glenmark Investigational Site 19, Bethesda

27262-4320

Glenmark Investigational Site 3, High Point

97504-9741

Glenmark Investigational Site 4, Medford

78028-6071

Glenmark Investigational Site 24, Kerrville

78229-3749

Glenmark Investigational Site 7, San Antonio

All Listed Sponsors
lead

Glenmark Specialty S.A.

INDUSTRY

NCT03463031 - Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR) | Biotech Hunter | Biotech Hunter